Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8969219rdf:typepubmed:Citationlld:pubmed
pubmed-article:8969219lifeskim:mentionsumls-concept:C0079870lld:lifeskim
pubmed-article:8969219lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8969219lifeskim:mentionsumls-concept:C0002003lld:lifeskim
pubmed-article:8969219lifeskim:mentionsumls-concept:C0012771lld:lifeskim
pubmed-article:8969219lifeskim:mentionsumls-concept:C0205463lld:lifeskim
pubmed-article:8969219pubmed:issue52lld:pubmed
pubmed-article:8969219pubmed:dateCreated1997-1-28lld:pubmed
pubmed-article:8969219pubmed:abstractTextAldose reductase is inactivated by physiological disulfides such as GSSG and cystine. To study the mechanism of disulfide-induced enzyme inactivation, we examined the rate and extent of enzyme inactivation using wild-type human aldose reductase and mutants containing cysteine-to-serine substitutions at positions 80 (C80S), 298 (C298S), and 303 (C303S). The wild-type, C80S, and C303S enzymes lost >80% activity following incubation with GSSG, whereas the C298S mutant was not affected. Loss of activity correlated with enzyme thiolation. The binary enzyme-NADP+ complex was less susceptible to enzyme thiolation than the apoenzyme. These results suggest that thiolation of human aldose reductase occurs predominantly at Cys-298. Energy minimization of a hypothetical enzyme complex modified by glutathione at Cys-298 revealed that the glycyl carboxylate of glutathione may participate in a charged interaction with His-110 in a manner strikingly similar to that involving the carboxylate group of the potent aldose reductase inhibitor Zopolrestat. In contrast to what was observed with GSSG and cystine, cystamine inactivated the wild-type enzyme as well as all three cysteine mutants. This suggests that cystamine-induced inactivation of aldose reductase does not involve modification of cysteines exclusively at position 80, 298, or 303.lld:pubmed
pubmed-article:8969219pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:languageenglld:pubmed
pubmed-article:8969219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:citationSubsetIMlld:pubmed
pubmed-article:8969219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8969219pubmed:statusMEDLINElld:pubmed
pubmed-article:8969219pubmed:monthDeclld:pubmed
pubmed-article:8969219pubmed:issn0021-9258lld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:QuiochoF AFAlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:MuraUUlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:MarinoCClld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:Dal MonteMMlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:WilsonD KDKlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:PetrashJ MJMlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:Del CorsoAAlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:CappielloMMlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:VoltarelliMMlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:CecconiIIlld:pubmed
pubmed-article:8969219pubmed:authorpubmed-author:VilardoP GPGlld:pubmed
pubmed-article:8969219pubmed:issnTypePrintlld:pubmed
pubmed-article:8969219pubmed:day27lld:pubmed
pubmed-article:8969219pubmed:volume271lld:pubmed
pubmed-article:8969219pubmed:ownerNLMlld:pubmed
pubmed-article:8969219pubmed:authorsCompleteYlld:pubmed
pubmed-article:8969219pubmed:pagination33539-44lld:pubmed
pubmed-article:8969219pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:meshHeadingpubmed-meshheading:8969219-...lld:pubmed
pubmed-article:8969219pubmed:year1996lld:pubmed
pubmed-article:8969219pubmed:articleTitleSpecifically targeted modification of human aldose reductase by physiological disulfides.lld:pubmed
pubmed-article:8969219pubmed:affiliationDipartimento di Fisiologia e Biochimica, Università di Pisa, via S. Maria 55, 56100 Pisa, Italy. cmario@dfb.unipi.itlld:pubmed
pubmed-article:8969219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8969219pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8969219pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8969219lld:pubmed